AKT1 and neoplasm: Firstly, it regulates pro-cancer signaling pathways: activating AKT/mTOR (e.g., hepatocellular carcinoma) [71], Wnt/β-catenin, and other pathways to promote tumor progression, indirectly forming an immunosuppressive microenvironment.